Oisín Biotechnologies
Oisín Biotechnologies is a biotechnology company developing genetic medicines to treat age-related diseases. They utilize the Fusogenix Proteo-Lipid Vehicle (PLV) technology for targeted DNA delivery, focusing initially on therapies to eliminate unwanted fat cells and build muscle mass.
Funding Round: Series A
Funding Amount: $15M
Date: 24-Jul-2024
Investors: AbbVie Ventures
Markets: Biotechnology, Genetic Medicine, Biopharma, Medical
HQ: Seattle, Washington, United States
Founded: 2014
Website: https://www.oisinbio.com
LinkedIn: https://www.linkedin.com/company/oisin-biotechnologies
Twitter: https://twitter.com/OisinBio
Crunchbase: https://www.crunchbase.com/organization/oisin-biotechnologies-inc
Leave a Comment
Comments
No comments yet.